Literature DB >> 25632041

Dysfunction in the βII spectrin-dependent cytoskeleton underlies human arrhythmia.

Sakima A Smith1, Amy C Sturm1, Jerry Curran1, Crystal F Kline1, Sean C Little1, Ingrid M Bonilla1, Victor P Long1, Michael Makara1, Iuliia Polina1, Langston D Hughes1, Tyler R Webb1, Zhiyi Wei1, Patrick Wright1, Niels Voigt1, Deepak Bhakta1, Katherine G Spoonamore1, Chuansheng Zhang1, Raul Weiss1, Philip F Binkley1, Paul M Janssen1, Ahmet Kilic1, Robert S Higgins1, Mingzhai Sun1, Jianjie Ma1, Dobromir Dobrev1, Mingjie Zhang1, Cynthia A Carnes1, Matteo Vatta1, Matthew N Rasband1, Thomas J Hund1, Peter J Mohler2.   

Abstract

BACKGROUND: The cardiac cytoskeleton plays key roles in maintaining myocyte structural integrity in health and disease. In fact, human mutations in cardiac cytoskeletal elements are tightly linked to cardiac pathologies, including myopathies, aortopathies, and dystrophies. Conversely, the link between cytoskeletal protein dysfunction and cardiac electric activity is not well understood and often overlooked in the cardiac arrhythmia field. METHODS AND
RESULTS: Here, we uncover a new mechanism for the regulation of cardiac membrane excitability. We report that βII spectrin, an actin-associated molecule, is essential for the posttranslational targeting and localization of critical membrane proteins in heart. βII spectrin recruits ankyrin-B to the cardiac dyad, and a novel human mutation in the ankyrin-B gene disrupts the ankyrin-B/βII spectrin interaction, leading to severe human arrhythmia phenotypes. Mice lacking cardiac βII spectrin display lethal arrhythmias, aberrant electric and calcium handling phenotypes, and abnormal expression/localization of cardiac membrane proteins. Mechanistically, βII spectrin regulates the localization of cytoskeletal and plasma membrane/sarcoplasmic reticulum protein complexes, including the Na/Ca exchanger, ryanodine receptor 2, ankyrin-B, actin, and αII spectrin. Finally, we observe accelerated heart failure phenotypes in βII spectrin-deficient mice.
CONCLUSIONS: Our findings identify βII spectrin as critical for normal myocyte electric activity, link this molecule to human disease, and provide new insight into the mechanisms underlying cardiac myocyte biology.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  arrhythmias, cardiac; catecholaminergic polymorphic ventricular arrhythmia; cytoskeleton; ion channels; protein transport; ventricular tachycardia

Mesh:

Substances:

Year:  2015        PMID: 25632041      PMCID: PMC4342332          DOI: 10.1161/CIRCULATIONAHA.114.013708

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  47 in total

1.  Mice with the R176Q cardiac ryanodine receptor mutation exhibit catecholamine-induced ventricular tachycardia and cardiomyopathy.

Authors:  Prince J Kannankeril; Brett M Mitchell; Sanjeewa A Goonasekera; Mihail G Chelu; Wei Zhang; Subeena Sood; Debra L Kearney; Cristina I Danila; Mariella De Biasi; Xander H T Wehrens; Robia G Pautler; Dan M Roden; George E Taffet; Robert T Dirksen; Mark E Anderson; Susan L Hamilton
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-27       Impact factor: 11.205

2.  Plakophilin-2 mutations are the major determinant of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy.

Authors:  J Peter van Tintelen; Mark M Entius; Zahurul A Bhuiyan; Roselie Jongbloed; Ans C P Wiesfeld; Arthur A M Wilde; Jasper van der Smagt; Ludolf G Boven; Marcel M A M Mannens; Irene M van Langen; Robert M W Hofstra; Luuk C Otterspoor; Pieter A F M Doevendans; Luz-Maria Rodriguez; Isabelle C van Gelder; Richard N W Hauer
Journal:  Circulation       Date:  2006-03-27       Impact factor: 29.690

3.  Deficient red-cell spectrin in severe, recessively inherited spherocytosis.

Authors:  P Agre; E P Orringer; V Bennett
Journal:  N Engl J Med       Date:  1982-05-13       Impact factor: 91.245

4.  Degradation of unassembled alpha- and beta-spectrin by distinct intracellular pathways: regulation of spectrin topogenesis by beta-spectrin degradation.

Authors:  C M Woods; E Lazarides
Journal:  Cell       Date:  1985-04       Impact factor: 41.582

5.  Spectrin mutations cause spinocerebellar ataxia type 5.

Authors:  Yoshio Ikeda; Katherine A Dick; Marcy R Weatherspoon; Dan Gincel; Karen R Armbrust; Joline C Dalton; Giovanni Stevanin; Alexandra Dürr; Christine Zühlke; Katrin Bürk; H Brent Clark; Alexis Brice; Jeffrey D Rothstein; Lawrence J Schut; John W Day; Laura P W Ranum
Journal:  Nat Genet       Date:  2006-01-22       Impact factor: 38.330

6.  Abnormal interactions of calsequestrin with the ryanodine receptor calcium release channel complex linked to exercise-induced sudden cardiac death.

Authors:  Dmitry Terentyev; Alessandra Nori; Massimo Santoro; Serge Viatchenko-Karpinski; Zuzana Kubalova; Inna Gyorke; Radmila Terentyeva; Srikanth Vedamoorthyrao; Nico A Blom; Giorgia Valle; Carlo Napolitano; Simon C Williams; Pompeo Volpe; Silvia G Priori; Sandor Gyorke
Journal:  Circ Res       Date:  2006-04-06       Impact factor: 17.367

7.  A cardiac arrhythmia syndrome caused by loss of ankyrin-B function.

Authors:  Peter J Mohler; Igor Splawski; Carlo Napolitano; Georgia Bottelli; Leah Sharpe; Katherine Timothy; Silvia G Priori; Mark T Keating; Vann Bennett
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-03       Impact factor: 11.205

8.  Differential regulation of two types of intracellular calcium release channels during end-stage heart failure.

Authors:  L O Go; M C Moschella; J Watras; K K Handa; B S Fyfe; A R Marks
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

9.  Focal mechanisms underlying ventricular tachycardia during prolonged ischemic cardiomyopathy.

Authors:  S M Pogwizd
Journal:  Circulation       Date:  1994-09       Impact factor: 29.690

10.  Biogenesis of the avian erythroid membrane skeleton: receptor-mediated assembly and stabilization of ankyrin (goblin) and spectrin.

Authors:  R T Moon; E Lazarides
Journal:  J Cell Biol       Date:  1984-05       Impact factor: 10.539

View more
  34 in total

Review 1.  Spectrin's chimeric E2/E3 enzymatic activity.

Authors:  Steven R Goodman; Rachel Petrofes Chapa; Warren E Zimmer
Journal:  Exp Biol Med (Maywood)       Date:  2015-08

2.  Novel Variant in the ANK2 Membrane-Binding Domain Is Associated With Ankyrin-B Syndrome and Structural Heart Disease in a First Nations Population With a High Rate of Long QT Syndrome.

Authors:  Leigh Anne Swayne; Nathaniel P Murphy; Sirisha Asuri; Lena Chen; Xiaoxue Xu; Sarah McIntosh; Chao Wang; Peter J Lancione; Jason D Roberts; Charles Kerr; Shubhayan Sanatani; Elizabeth Sherwin; Crystal F Kline; Mingjie Zhang; Peter J Mohler; Laura T Arbour
Journal:  Circ Cardiovasc Genet       Date:  2017-01

3.  Dysfunction of the β2-spectrin-based pathway in human heart failure.

Authors:  Sakima A Smith; Langston D Hughes; Crystal F Kline; Amber N Kempton; Lisa E Dorn; Jerry Curran; Michael Makara; Tyler R Webb; Patrick Wright; Niels Voigt; Philip F Binkley; Paul M L Janssen; Ahmet Kilic; Cynthia A Carnes; Dobromir Dobrev; Matthew N Rasband; Thomas J Hund; Peter J Mohler
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-04-22       Impact factor: 4.733

4.  Cell-autonomous adiposity through increased cell surface GLUT4 due to ankyrin-B deficiency.

Authors:  Damaris N Lorenzo; Vann Bennett
Journal:  Proc Natl Acad Sci U S A       Date:  2017-11-13       Impact factor: 11.205

Review 5.  Supporting the heart: Functions of the cardiomyocyte's non-sarcomeric cytoskeleton.

Authors:  Kelly M Grimes; Vikram Prasad; James W McNamara
Journal:  J Mol Cell Cardiol       Date:  2019-04-09       Impact factor: 5.000

Review 6.  Electrophysiological and molecular mechanisms of paroxysmal atrial fibrillation.

Authors:  Stanley Nattel; Dobromir Dobrev
Journal:  Nat Rev Cardiol       Date:  2016-08-04       Impact factor: 32.419

7.  Defining the molecular signatures of human right heart failure.

Authors:  Jordan L Williams; Omer Cavus; Emefah C Loccoh; Sara Adelman; John C Daugherty; Sakima A Smith; Benjamin Canan; Paul M L Janssen; Sara Koenig; Crystal F Kline; Peter J Mohler; Elisa A Bradley
Journal:  Life Sci       Date:  2018-01-31       Impact factor: 5.037

Review 8.  The role of βII spectrin in cardiac health and disease.

Authors:  Mohamed H Derbala; Aaron S Guo; Peter J Mohler; Sakima A Smith
Journal:  Life Sci       Date:  2017-11-09       Impact factor: 5.037

Review 9.  Genetics and genomics of autism spectrum disorder: embracing complexity.

Authors:  Silvia De Rubeis; Joseph D Buxbaum
Journal:  Hum Mol Genet       Date:  2015-07-17       Impact factor: 6.150

10.  Elevated local [Ca2+] and CaMKII promote spontaneous Ca2+ release in ankyrin-B-deficient hearts.

Authors:  Iuliana Popescu; Samuel Galice; Peter J Mohler; Sanda Despa
Journal:  Cardiovasc Res       Date:  2016-04-30       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.